K
Kalekim Kimyevi Maddeler Sanayi ve Ticaret AS
IST:KLKIM.E
Kalekim Kimyevi Maddeler Sanayi ve Ticaret AS
IST:KLKIM.E
Price:
31.24
TRY
2.63%
Market Cap:
14.4B
TRY
Balance Sheet
Balance Sheet Decomposition
Kalekim Kimyevi Maddeler Sanayi ve Ticaret AS
Kalekim Kimyevi Maddeler Sanayi ve Ticaret AS
| Current Assets | 3.9B |
| Cash & Short-Term Investments | 1.8B |
| Receivables | 1.4B |
| Other Current Assets | 721.4m |
| Non-Current Assets | 2.7B |
| Long-Term Investments | 190.2m |
| PP&E | 2.1B |
| Intangibles | 233.8m |
| Other Non-Current Assets | 163m |
Balance Sheet
Kalekim Kimyevi Maddeler Sanayi ve Ticaret AS
Kalekim Kimyevi Maddeler Sanayi ve Ticaret AS
Currency: TRY
Millions
Annual
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
15
|
20
|
34
|
39
|
183
|
328
|
135
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
106
|
0
|
|
| Cash Equivalents |
15
|
20
|
34
|
39
|
183
|
222
|
134
|
|
| Short-Term Investments |
11
|
53
|
90
|
414
|
720
|
702
|
1 665
|
|
| Total Receivables |
100
|
109
|
126
|
198
|
829
|
1 099
|
1 376
|
|
| Accounts Receivables |
96
|
106
|
119
|
198
|
826
|
1 016
|
1 343
|
|
| Other Receivables |
3
|
3
|
7
|
0
|
3
|
83
|
33
|
|
| Inventory |
32
|
24
|
35
|
76
|
395
|
379
|
547
|
|
| Other Current Assets |
7
|
6
|
10
|
27
|
56
|
118
|
174
|
|
| Total Current Assets |
165
|
212
|
295
|
753
|
2 183
|
2 625
|
3 896
|
|
| PP&E Net |
93
|
104
|
124
|
153
|
846
|
1 312
|
2 100
|
|
| PP&E Gross |
93
|
104
|
124
|
153
|
846
|
0
|
2 100
|
|
| Accumulated Depreciation |
79
|
90
|
100
|
88
|
996
|
0
|
1 685
|
|
| Intangible Assets |
3
|
7
|
14
|
15
|
136
|
134
|
169
|
|
| Goodwill |
0
|
0
|
0
|
0
|
45
|
52
|
65
|
|
| Note Receivable |
0
|
0
|
0
|
1
|
2
|
2
|
3
|
|
| Long-Term Investments |
20
|
22
|
30
|
60
|
135
|
163
|
190
|
|
| Other Long-Term Assets |
16
|
16
|
7
|
2
|
46
|
152
|
160
|
|
| Other Assets |
0
|
0
|
0
|
0
|
45
|
52
|
65
|
|
| Total Assets |
297
N/A
|
361
+22%
|
470
+30%
|
984
+109%
|
3 393
+245%
|
4 440
+31%
|
6 583
+48%
|
|
| Liabilities | ||||||||
| Accounts Payable |
9
|
3
|
5
|
3
|
18
|
843
|
20
|
|
| Accrued Liabilities |
4
|
6
|
9
|
14
|
55
|
85
|
117
|
|
| Short-Term Debt |
71
|
96
|
165
|
236
|
745
|
252
|
1 029
|
|
| Current Portion of Long-Term Debt |
9
|
59
|
5
|
5
|
15
|
18
|
330
|
|
| Other Current Liabilities |
9
|
27
|
26
|
58
|
170
|
226
|
362
|
|
| Total Current Liabilities |
102
|
191
|
209
|
316
|
1 003
|
1 423
|
1 859
|
|
| Long-Term Debt |
64
|
6
|
13
|
9
|
19
|
29
|
42
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
9
|
42
|
54
|
|
| Minority Interest |
0
|
0
|
0
|
1
|
102
|
145
|
242
|
|
| Other Liabilities |
7
|
7
|
10
|
15
|
77
|
42
|
50
|
|
| Total Liabilities |
173
N/A
|
205
+18%
|
231
+13%
|
339
+47%
|
1 209
+256%
|
1 680
+39%
|
2 246
+34%
|
|
| Equity | ||||||||
| Common Stock |
100
|
100
|
100
|
115
|
115
|
460
|
460
|
|
| Retained Earnings |
29
|
58
|
145
|
345
|
1 627
|
1 851
|
3 293
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
197
|
683
|
786
|
986
|
|
| Unrealized Security Profit/Loss |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
|
| Treasury Stock |
0
|
0
|
0
|
8
|
20
|
23
|
29
|
|
| Other Equity |
4
|
4
|
6
|
5
|
221
|
313
|
373
|
|
| Total Equity |
125
N/A
|
157
+26%
|
239
+53%
|
645
+170%
|
2 184
+239%
|
2 760
+26%
|
4 338
+57%
|
|
| Total Liabilities & Equity |
297
N/A
|
361
+22%
|
470
+30%
|
984
+109%
|
3 393
+245%
|
4 440
+31%
|
6 583
+48%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
460
|
460
|
460
|
460
|
460
|
460
|
460
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
